Background: To determine the prevalence of specific musculoskeletal disorders in coal miners, and associated occupational risk factors in order to provide reliable epidemiologic data for targeted interventions. Methods: 1900 coal miners in China were examined in a crosssectional study. Musculoskeletal disorders in the neck, shoulder, upper-extremity, the back and low limbs were assessed using the Standardized Nordic Questionnaire. Odds ratios and 95% confidence intervals (CIs) were calculated to examine occupational factors in relation to any specific musculoskeletal disorder using logistic regression. Results: There were 1205 coal miners, in a year, who suffered from musculoskeletal disorders. Low back pain was the most common musculoskeletal disorder with 59.5% of prevalence. The prevalence of musculoskeletal disorders increased with age. The prevalence of underground workers was significantly higher than that of the surface workers (79.6% vs 74.5%, P < 0.001). Neck/shoulder and upperextremity musculoskeletal disorders were associated with high repetitiveness (OR 1.6, 95% CI 1.3-2.0) and awkward work (OR 1.3, 95% CI 1.1-1.6). High repetitiveness (OR 1.5, 95% CI 1.1-1.8), high physical demand (OR 1.5, 95% CI 1.2-2.0) and extreme stooping posture (OR 1.9, 95% CI 1.4-2.7) were strongly related to low-back pain. Low limb disorders were associated with long standing (OR 1.4, 95% CI 1.1-1.7) and awkward work (OR 1.4, 95% CI 1.1-1.7) Conclusions: This study identified associations between specific musculoskeletal disorders and occupational factors among coal miners. Intervention strategies of occupational factors may be helpful to reduce musculoskeletal disease burden. Disclosure statement: The authors have declared no conflicts of interest. Background: Fatigue is common and has a major impact on quality of life in RA and SLE. In these conditions, fatigue correlates with central factors such as depression and mood. The frequency, origins and impact of fatigue in DM and PM have not previously been evaluated. Methods: 100 patients with DM and PM were recruited from three South London teaching hospitals. Patients were first asked to rate seven typical IIM symptoms (pain, weakness, fatigue, daily functioning, sleep, memory, gastrointestinal upset) in the order of impact on quality of life. They also rated each symptom on a severity scale out of 6. Fatigue levels were measured with three generic tools (FACIT-F, fatigue severity scale (FSS) and the vitality component of SF-36. Mood was measured using the hospital anxiety and depression scale 119 (17) 96 (15) 99 (15) 92 (15) 83 (14) 61 (10) 36 (7) 41 (9) 39 (9) 38 (8) Number other combination (2 or more of dmards, steroid, biologic (%)
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59 (8) 58 (9) 56 (9) 58 (9) 60 (10) 52 (8) 65 (12) 65 (14) 71 (17) 73 (15) (HADS), quality of life by SF-36 and pain with a visual analogue scale (VAS). Spearman's correlation (r>þ/-0.6, p < 0.05) evaluated fatigue against these measures. Background: Fatigue is commonly reported by patients with idiopathic inflammatory myopathies (IIM). The relative contribution of physiological and psychological factors, however, is not known. Muscle endurance can be defined as the ability of a muscle to sustain repeated contractions against a resistance for a period of time. It has been suggested that poor muscle endurance is likely to be a key factor in IIM. We used a non-volitional technique to assess quadriceps muscle endurance in IIM patients and healthy age matched controls. We also assessed whether there was a relationship between selfreported fatigue and muscle endurance. Methods: Endurance Protocol: muscle endurance was assessed using repetitive transcutaneous electrical stimulation applied using pads placed over the quadriceps muscle. The muscle was stimulated repeatedly for 3 mins, at 30Hz 250 ms on, 750 ms off, at a voltage which initially elicited 30% of the maximal voluntary contraction (MVC) force measured prior to the endurance test. The force generated by each quadriceps contraction (Kg) was recorded using a strain gauge attached to the to the subject's ankle via an inelastic strap. Selfreported fatigue was measured using the FACIT-F questionnaire. We compared mean time for initial starting force to decline to 70% between patients and controls (unpaired t tests). We also investigated whether this correlated with fatigue (FACIT-F) using Spearman's correlation. Results: We compared 20 IIM patients (16 dermatomoyositis and 4 polymositis; 10 females, 10 males) with age and sex matched controls. Fatigue measured by FACIT-F and FSS was significantly reduced in the patients (Table 1) . Quadriceps strength was also significantly reduced in the patients. In contrast, there was no difference in quadriceps endurance between the patients and controls. No relationship was found between measures of fatigue (FACIT-F and FSS) and quadriceps endurance or quadriceps strength in IIM patients. Conclusions: Patients with IIM have greater self-reported fatigue than matched controls. However, although quadriceps muscle strength was reduced in IIM, there were no differences in quadriceps muscle endurance. Quadriceps muscle endurance and muscle strength were also unrelated to self-reported fatigue which is almost certainly driven by central mechanisms in IIM. The impact of IIM on quadriceps muscle strength rather than muscle endurance may influence types of rehabilitation programs offered for IIM. Disclosure statement: The authors have declared no conflicts of interest. Background: Screening for autoantibodies associated with idiopathic inflammatory myopathies (IIM) has conventionally been performed using radio-immunoprecipitation techniques which are not suitable for use in routine diagnostic laboratories. We have investigated the use of line-immunoassay technology employing recombinant antigens as an alternative for this purpose. Methods: Sera and clinical data were collected on 486 patients (256 PM,183 DM, 20JDM, 9 IBM, 18 overlap syndrome) with IIM, according to Bohan and Peter or Grigg's criteria, from 3 European centres as part of the EUMyogen study. These were tested using a line-immunoassay system (Euroimmun, Lubeck, Germany). The system tested was able to detect 11 myositis associated antibodies (Jo-1, PL-7, PL-12, EJ, OJ, SRP, PM-Scl-75,PM-Scl-100, Ku, Mi-2B, U1-RNP). Patients were assesed for the presence of joint disease, interstitial lung disease (ILD), Gottron's papules, heliotrope rash and cancer (þ/-3 years of diagnosis). Sera from control rheumatic diseases (SLE, RA, Scleroderma n ¼ 399) were also tested. Results: Anti Jo-1 was the commonest antibody detected in the cohort (12.6%). Antibodies to PM-Scl (3.7%); U1-RNP (5.5%); SRP (2.6%); Mi-2b (2.6%); Ku (1.6%)EJ, PL-7 and PL-12 (all <1%) were also detected in the cohort. Significant clinical associations are summarised in Table 1. Antibodies to PM-Scl-100 were significantly associated with the presence of scleroderma overlap (p ¼ 0.0014 OR 11.9). None of the antibody specificities tested were associated with joint disease or cancer.
Antibodies to myositis associted antibodies were detected at low frequency in control groups, except for anti-Ku which was detected in 9/203 SLE (4.4%) patients. Conclusions: In this study, using recombinant protein lineimmunoassay technology, we have reported that antibodies to Jo-1, SRP and PM-Scl are associated with the presence of ILD, and that antibodies to Mi-2B are associated with the presence of Gottron's papules. In addition antibodies to Jo-1 and U1 RNP show a negative association with the presence of Gottron's papules and heliotrope rash. In addition anti-Ku is found more frequently in SLE than in IIM. Detection of myositis associated antibodies using line-immunoassay technology employing recombinant protein antigens is a fast and reporducible method, which is easy to perform, and which will allow the assaying of these antibodies in routine clinical laboratorie Disclosure statement: The authors have declared no conflicts of interest. Background: The idiopathic inflammatory myopathies (IIM) are a heterogenous group of rare autoimmune muscle disorders subclassified into polymyositis (PM), dermatomyositis (DM) and inclusion body myositis (IBM). Delays in diagnosis, poor response to treatment and difficulty in recognising active muscle disease may lead to irreversible muscle / internal organ damage. Careful investigation of disease mechanisms, refinement of classification and tools for earlier diagnosis are urgently required, to improve future IIM clinical outcomes. Our aim was to obtain uniform, longitudinal follow-up data in large wellcharacterised IIM cohorts as part of an international collaboration. Methods: The EUROMYOSITIS register was developed within the European FP6 AutoCure project. Since 2010, further development and support has been via the European Science Foundation Research Networking Programme, EuMyoNet. A Delphi process, followed by consensus discussion among rheumatology / neurology experts, was employed to decide on included variables. DANBIO, a Danish-wide rheumatoid arthritis open source register, based on the core technologies Plone and R, was used as a basis. The EUROMYOSITIS register has 2 parts: 1) basic data including demographic data and diagnostic information; 2) outcome measures proposed and validated by the International Myositis Assessment and Clinical Studies Group (IMACS). Serial longitudinal data is displayed in scoreboard format for ease of clinical interpretation. Only physicians in a particular centre view individual patient data, although combined anonymised analyses are possible on steering committee application.
Results: To date, 893 prevalent and incident cases (median age 59, interquartile range 49-67, 72% female) have been enrolled from 4 hospitals in 4 countries (UK n ¼ 222, Sweden n ¼ 123, Czech Republic n ¼ 190, Hungary n ¼ 358). Numbers were as follows on stratification by clinical sub-group: 487 PM (54.5%), 287 DM (32.1%), 41 IBM (4.6%), 29 juvenile DM (3.2%), 5 amyopathic DM (0.6%) and 42 unspecified myositis (4.7%). Median disease duration at first input in the register was 4 years (interquartile range 1-10). Mean value of the following physicians rated parameters all on a visual analogue scale (0-100AEstandard deviation) at inclusion/last observations was: overall disease activity 4AE6.1, overall muscle disease activity 11.1AE14.2, overall muscle damage 15.5AE19.7. Median HAQ score was 0.75 (0.13-1.25) and MMT8 (manual muscle testing ranging from 0-80) 75 (67-79).
Conclusions:
The EUROMYOSITIS register is a novel electronic register for both clinical and research to follow IIM cases in a standardised manner (www.euromyositis.eu). It will be available for users without any costs after adequate ethical permits have been achieved and when legal agreements have been signed with the steering committee. The EUROMYOSITIS register will facilitate future IIM clinical research and will serve as a platform for future clinical trials. Background: Although the role of vitamin D deficiency in causing osteomalacia is well recognised, there is limited evidence to suggest that vitamin D deficiency is associated with osteoporosis. One community based study has suggested a reduction in bone density in females with low vitamin D levels, while another has shown no effect of isolated vitamin D deficiency on population fracture rates. We aimed to assess bone density in a cohort of women with low vitamin D levels but no other identified risk factors for osteoporosis. We wished to see if there was any relationship between the two, in order to clarify whether measurement of vitamin D was justified in aiding selection of patients for DXA, and whether DXA was justified in patients found to have isolated vitamin D deficiency. Methods: We identified 70 women referred to an open access DXA scanning service by their GP with low vitamin D levels (under 48 nmol/l) as their only risk factor. We performed DXA of hip and spine and recorded the absolute bone density and Z scores for each patient, together with their vitamin D levels. We calculated the mean (SD) values for Z score at hip and spine, and compared these to a control group of women referred for baseline DXA prior to commencing aromatase inhibitors for breast cancer. We also compared the results with those obtained from the rest of the GP database for women referred up with a 10 year risk of osteoporotic fractures calculated at over 10% using FRAX. These statistical comparisons were made using unpaired Students t test. Mean values for Z scores at hip and spine were calculated and compared within the index group for those with vitamin D levels above and below 20 nmol/l using Students t test. Correlation coefficients between vitamin D levels and Z scores at hip and spine were also calculated for the index group. Background: Patients who sustain low trauma fractures are at a higher risk of osteoporosis and further fractures. However, it is not known whether metatarsal fractures also increase the chance that the patient will have low Bone Mineral Density (BMD). Methods: We retrospectively analysed data from our community based fracture liaison service on 68 post-menopausal women who had sustained a low trauma metatarsal fracture. Routine assessment of these patients included; identification of risk factors for fracture (smoking, alcohol consumption, early menopause, family history of fracture, and medical conditions associated with low BMD); height and weight measurement; and measurement of peripheral bone density at the heel by DXA (Calscan, Demitech). To compare BMD levels in our group of fracture patients with the reference population in the Calscan database, we evaluated the proportion of individuals with a Z-score of À1 Standard Deviation (SD). Assuming a normal distribution, the risk is 0.68 of being within þ / -1 SD of the mean, and thus the expected proportion of Z-scores À1 SD is 16% by default. Similarly, the risk of being within 2 SD of the mean is 0.95, and therefore the expected proportion of Z-scores À2 is 2.5%. The 95% Confidence Intervals (CI) range for the proportions of patients with a Z-score À1 SD, and À2 SD, were calculated using the equation for binomial distribution. Results: The mean age (SD) of the patients was 69.0 (9.8) years, and the mean Body Mass Index was 27.7 (5.47) Kg / m2. The 68 patients had the following risk factors for fracture; early menopause 1 patient, family history of fracture 1 patient, smoking 6 patients, and alcohol
